University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Aug 26,2019: Genetic cues to ovarian cancer explored
Aug 22,2019: MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
Aug 21,2019: MD Anderson receives more than $19 million in CPRIT funding
Aug 14,2019: Boehringer partners with MD Anderson on virtual R&D centre
Jul 15,2019: New biomarker-guided strategy has potential for liver cancer treatment

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.




Section 1 - About the Company
University of Texas MD Anderson Cancer Center - Key Facts
University of Texas MD Anderson Cancer Center - Key Employees
University of Texas MD Anderson Cancer Center - Key Employee Biographies
University of Texas MD Anderson Cancer Center - Major Products and Services
University of Texas MD Anderson Cancer Center - History
University of Texas MD Anderson Cancer Center - Company Statement
University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
University of Texas MD Anderson Cancer Center - Business Description
Business Segment: Auxillary Income
Performance
Business Segment: Investment and Other Non-operating Income
Performance
Business Segment: Net Patient Revenue
Performance
Business Segment: Other Income
Performance
Business Segment: Restricted Grants and Contracts, Philanthropy
Performance
Business Segment: State-appropriated General Revenue
Performance
R&D Overview
University of Texas MD Anderson Cancer Center - Corporate Strategy
University of Texas MD Anderson Cancer Center - SWOT Analysis
SWOT Analysis - Overview
University of Texas MD Anderson Cancer Center - Strengths
University of Texas MD Anderson Cancer Center - Weaknesses
University of Texas MD Anderson Cancer Center - Opportunities
University of Texas MD Anderson Cancer Center - Threats
University of Texas MD Anderson Cancer Center - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 4 Companys Recent Developments
Aug 26, 2019: Genetic cues to ovarian cancer explored
Aug 22, 2019: MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
Aug 21, 2019: MD Anderson receives more than $19 million in CPRIT funding
Aug 14, 2019: Boehringer partners with MD Anderson on virtual R&D centre
Jul 15, 2019: New biomarker-guided strategy has potential for liver cancer treatment
Jun 21, 2019: AACR conference features latest research on impact of environmental carcinogens and potential pathways to cancer prevention
Jun 10, 2019: Study finds macrophages pathway to nurture PTEN-deficient glioblastoma
May 02, 2019: New cancer therapy target found in mitochondria for potential treatment of blood cancers
Mar 27, 2019: New potential therapeutic target for pancreatic cancer discovered
Mar 20, 2019: NCCN announces six quality improvement projects in Gastric Cancer care approved for collaboration with Lilly Oncology
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


University of Texas MD Anderson Cancer Center, Key Facts
University of Texas MD Anderson Cancer Center, Key Employees
University of Texas MD Anderson Cancer Center, Key Employee Biographies
University of Texas MD Anderson Cancer Center, Major Products and Services
University of Texas MD Anderson Cancer Center, History
University of Texas MD Anderson Cancer Center, Other Locations
University of Texas MD Anderson Cancer Center, Subsidiaries
University of Texas MD Anderson Cancer Center, Joint Venture
University of Texas MD Anderson Cancer Center, Key Competitors
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
University of Texas MD Anderson Cancer Center, Recent Deals Summary

List Of Figures


University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available